Clinical trial · Interventional
Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer
NCT04661046CI-TRIAL-00048729unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To explore the correlation between gene mutations of metastatic colorectal cancer and TCM syndrome types based on Second-generation sequencing technology.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gene Mutation-Related Cancer | — | UNRESOLVED | — |
| Traditional Chinese Medicine | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Traditional Chinese Medicine | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- TCM Syndrome Types
- description
- Traditional Chinese Medicine
- interventionNames
- Drug: Traditional Chinese Medicine
Primary outcomes (2)
- measure
- Overall Survival
- timeFrame
- 2 years
- description
- OS
- measure
- Progression Free Survival
- timeFrame
- 2 years
- description
- PFS
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. A clear pathological diagnosis is a patient with colorectal cancer; 2. Have complete TNM staging information; 3. There is a clear diagnosis of the location and time of metastasis; 4. Age ≥18 years old, ≤80 years old, male or female; 5. There is a clear time for the first treatment with Chinese medicine; 6. Patients who can receive long-term follow-up. - Exclusion Criteria: 1. Patients with colorectal cancer diagnosed pathologically as adenosquamous carcinoma, squamous cell carcinoma, carcinoid, small cell carcinoma, malignant lymphoma, etc.; 2. Patients with double cancer, multiple or metastatic colorectal cancer; 3. Combined with severe acute and chronic diseases that may affect treatment and prognosis, such as myocardial infarction, stroke, severe renal insufficiency and mental illness;-
References
Publications (0)
Data not yet available
No reference posted for this study.